Addex Therapeutics (ADXN) Invested Capital (2022 - 2024)
Historic Invested Capital for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $11.0 million.
- Addex Therapeutics' Invested Capital rose 75545.03% to $11.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.0 million, marking a year-over-year increase of 75545.03%. This contributed to the annual value of $11.0 million for FY2024, which is 76248.09% up from last year.
- According to the latest figures from Q4 2024, Addex Therapeutics' Invested Capital is $11.0 million, which was up 75545.03% from $1.3 million recorded in Q4 2023.
- In the past 5 years, Addex Therapeutics' Invested Capital ranged from a high of $11.0 million in Q4 2024 and a low of $1.3 million during Q4 2023
- For the 3-year period, Addex Therapeutics' Invested Capital averaged around $5.8 million, with its median value being $5.1 million (2022).
- In the last 5 years, Addex Therapeutics' Invested Capital crashed by 7467.81% in 2023 and then skyrocketed by 75545.03% in 2024.
- Addex Therapeutics' Invested Capital (Quarter) stood at $5.1 million in 2022, then crashed by 74.68% to $1.3 million in 2023, then skyrocketed by 755.45% to $11.0 million in 2024.
- Its last three reported values are $11.0 million in Q4 2024, $1.3 million for Q4 2023, and $5.1 million during Q4 2022.